Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-21-004522

President sold 15,000 shares at an average $66.23 ($993,417)

  • President acquired 15,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
RUBINSTEIN JULIE President 2021-01-15 Option exercise +15,000 $6.32 $94,800 15,000 D: show line 1 in the form
RUBINSTEIN JULIE President 2021-01-15 Sale −4,707 $65.47 $308,167 10,293 D: show line 2 in the form
RUBINSTEIN JULIE President 2021-01-15 Sale −8,802 $66.47 $585,069 1,491 D: show line 3 in the form
RUBINSTEIN JULIE President 2021-01-15 Sale −1,491 $67.19 $100,180 0 D: show line 4 in the form
Open-market sales · 15,000 sh · avg $66.23 · $993,417

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
RUBINSTEIN JULIE President 2021-01-15 Option exercise · Stock Option (Right to Buy) −15,000 230,000 D: show line 5 in the form
Loading xslF345X03/doc4.xml…